logo
Select company
Select metric
$ -58.41MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
11
Sector
29
Industry
42
History
55
$ 1.2Close
$ 1.1 - $ 4.29 52-Week Range
Ticker Information

Ticker

GERN

Company Name

GERON CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

GERON CORP - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GERN - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 1.13M$ -59.54M$ -58.41M
3/31/2025$ 1.25M$ -115.75M$ -114.49M
12/31/2024$ 1.22M$ -156.07M$ -154.85M
9/30/2024$ 1.15M$ -189.07M$ -187.93M
6/30/2024$ 1.21M$ -208.41M$ -207.2M
3/31/2024$ 1.06M$ -191.57M$ -190.51M
12/31/2023$ 1.03M$ -175.81M$ -174.78M
9/30/2023$ 1.02M$ -166.79M$ -165.77M
6/30/2023$ 980K$ -163.29M$ -162.31M
3/31/2023$ 921K$ -142.6M$ -141.68M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • GERON CORP's latest trailing twelve months (TTM) EBITDA stands at $ -79.38M.
  • Over the past 5 years, GERON CORP's average EBITDA has been $ -129.59M.
  • The median EBITDA for GERON CORP during this period was $ -119.45M
  • GERON CORP reached its highest EBITDA over the past 5 years at $ -58.41M.
  • The lowest EBITDA recorded by GERON CORP in the same timeframe $ -207.2M

GERON CORP's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
ZYME : ZYMEWORKS INC $ -54.55MAKBA : AKEBIA THERAPEUTICS INC $ 15.38MDAWN : DAY ONE BIOPHARMACEUTICALS INC $ -86.04MCRMD : CORMEDIX INC $ 52.25MSTOK : STOKE THERAPEUTICS INC $ 44.92MNAGE : NIAGEN BIOSCIENCE INC $ 19.78MURGN : UROGEN PHARMA LTD $ -134.34MXNCR : XENCOR INC $ -123.36MDNA : GINKGO BIOWORKS HOLDINGS INC $ -222.12MSNDX : SYNDAX PHARMACEUTICALS INC $ -313.35M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for GERON CORP is calculated as follows: EBIT [ $ -80.88M ] + DepAmor [ $ 1.5M ]
(=) EBITDA [ $ -79.38M ]

GERN - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -207.2M

Minimum

Jun 30, 2024

$ -58.41M

Maximum

Jun 30, 2025

$ -129.59M

Average

$ -119.45M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.79M with a standard deviation of $ 166.94M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.79M
median$ 8.83M
std$ 166.94M